These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20193400)

  • 1. [Expression of Survivin protein in extrahepatic cholangiocarcinoma and its relationship with the prognosis].
    Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
    Zhonghua Wai Ke Za Zhi; 2009 Dec; 47(24):1852-6. PubMed ID: 20193400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of lymph node micrometastasis for patients with extrahepatic cholangiocarcinoma and its prognostic significance].
    Qin XL; Xue HZ; Wang ZR; Liu HS; Zhou HB; Ma W
    Zhonghua Yi Xue Za Zhi; 2010 Mar; 90(10):678-82. PubMed ID: 20450726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Lamininγ2 in extrahepatic cholangiocarcinoma tissues and its influence on tumor invasion and metastasis.
    Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
    Asian Pac J Cancer Prev; 2015; 16(5):2099-102. PubMed ID: 25773857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of LAPTM4B-35: a novel marker of progression, invasiveness and poor prognosis of extrahepatic cholangiocarcinoma.
    Zhou L; He XD; Cui QC; Zhou WX; Qu Q; Zhou RL; Rui JA; Yu JC
    Cancer Lett; 2008 Jun; 264(2):209-17. PubMed ID: 18334282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative Expression of DSG1 and DSG2, as Prognostic Biomarkers, Impacts on the Overall Survival in Patients with Extrahepatic Cholangiocarcinoma.
    Xu S; Huang S; Li D; Zou Q; Yuan Y; Yang Z
    Anal Cell Pathol (Amst); 2020; 2020():9831646. PubMed ID: 32850288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human G-protein gamma 7 in extrahepatic cholangiocarcinoma and its clinicopathological significance.
    Wang M; Gong B; Li Y; Wang Y
    Hematol Oncol Stem Cell Ther; 2010; 3(2):66-70. PubMed ID: 20543539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
    Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forkhead box protein C2 contributes to invasion and metastasis of extrahepatic cholangiocarcinoma, resulting in a poor prognosis.
    Watanabe A; Suzuki H; Yokobori T; Altan B; Kubo N; Araki K; Wada S; Mochida Y; Sasaki S; Kashiwabara K; Hosouchi Y; Kuwano H
    Cancer Sci; 2013 Nov; 104(11):1427-32. PubMed ID: 23919841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.
    Han Y; Zhang W; Liu Y
    World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BIRC7 and STC2 Expression Are Associated With Tumorigenesis and Poor Outcome in Extrahepatic Cholangiocarcinoma.
    Li J; Yang Z; Huang S; Li D
    Technol Cancer Res Treat; 2020; 19():1533033820971676. PubMed ID: 33234031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of cystathionine beta-synthase and chemokine ligand 21 is closely associated with poor prognosis in extrahepatic cholangiocarcinoma.
    Wang L; Yang Z; Wu Z; He J; Xu S; Li D; Zou Q; Yuan Y
    Medicine (Baltimore); 2020 Sep; 99(38):e22255. PubMed ID: 32957374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nerve Growth Factor Expression Is Not Associated with Perineural Invasion in Extrahepatic Cholangiocarcinoma.
    Urabe K; Murakami Y; Kondo N; Uemura K; Hashimoto Y; Nakagawa N; Sasaki H; Hiyama E; Takahashi S; Sueda T
    Dig Dis Sci; 2016 Mar; 61(3):774-84. PubMed ID: 26547754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma.
    Miyamoto M; Ojima H; Iwasaki M; Shimizu H; Kokubu A; Hiraoka N; Kosuge T; Yoshikawa D; Kono T; Furukawa H; Shibata T
    Br J Cancer; 2011 Jun; 105(1):131-8. PubMed ID: 21673683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expressions of HMGA2 and Thy1 in extrahepatic cholangiocarcinoma and their clinicopathological significances.
    Liu R; Yang Z; Huang S; Li D; Zou Q; Yuan Y
    Surg Oncol; 2019 Jun; 29():41-47. PubMed ID: 31196492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Impact of Paraaortic Lymph Node Metastasis in Extrahepatic Cholangiocarcinoma.
    Nitta N; Ohgi K; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Otsuka S; Sasaki K; Uesaka K
    World J Surg; 2021 Feb; 45(2):581-589. PubMed ID: 33079246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of aPKC-iota and E-cadherin expression with invasion and prognosis of cholangiocarcinoma.
    Li Q; Wang JM; Liu C; Xiao BL; Lu JX; Zou SQ
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):70-5. PubMed ID: 18234642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma.
    Tojima Y; Nagino M; Ebata T; Uesaka K; Kamiya J; Nimura Y
    Ann Surg; 2003 Feb; 237(2):201-7. PubMed ID: 12560778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray.
    Nitta T; Mitsuhashi T; Hatanaka Y; Miyamoto M; Oba K; Tsuchikawa T; Suzuki Y; Hatanaka KC; Hirano S; Matsuno Y
    Br J Cancer; 2014 Sep; 111(7):1363-72. PubMed ID: 25077440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between clinicopathological features and CA19-9/CEA in patients with extrahepatic cholangiocarcinoma].
    Tang X; Zhang J; Chen Y; Lan Z; Wang C
    Zhonghua Zhong Liu Za Zhi; 2014 Sep; 36(9):662-6. PubMed ID: 25564055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1 is a useful biomarker for invasive extrahepatic cholangiocarcinoma.
    Tabata Y; Nakanishi Y; Hatanaka KC; Hatanaka Y; Tsuchikawa T; Okamura K; Noji T; Shichinohe T; Matsuno Y; Hirano S
    Hum Pathol; 2018 Jun; 76():28-36. PubMed ID: 29447925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.